Seal Rock Therapeutics
PrivateLast Round
Grant
Mar 29, 2023
Total Funding Raised
$487,500
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Seal Rock Therapeutics is a biotechnology company that develops small-molecule inhibitors designed to treat inflammatory and fibrotic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seal Rock Therapeutics Comparables
Compare Seal Rock Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genfit S.A. | 78% | |
| Galmed Pharmaceuticals Ltd. | 78% | |
| Hepion Pharmaceuticals Inc | 77% |
Seal Rock Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 29, 2023 | ||||
| Series A | Oct 18, 2021 | ||||
| Seed | Jun 30, 2021 | ||||
| Seed | Sep 30, 2020 |
Key People
Founding team and executive leadership
Seal Rock Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 57% MoM.
- Jun 18, 2026
Monthly visitors increased 215% MoM.
Seal Rock Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Seal Rock Therapeutics's valuation, stock price, and market status.
Is Seal Rock Therapeutics a public or private company?
Seal Rock Therapeutics is a private company.
What is the current stock price of Seal Rock Therapeutics?
Seal Rock Therapeutics is a private company, so its shares have no public market price. Caplight tracks Seal Rock Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Seal Rock Therapeutics worth (valuation)?
Valuation information for Seal Rock Therapeutics is not publicly available.
Can I buy Seal Rock Therapeutics stock?
Seal Rock Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Seal Rock Therapeutics's last funding round?
Seal Rock Therapeutics's most recent funding round was Grant on March 29, 2023.
Who are the main investors in Seal Rock Therapeutics?
Key investors in Seal Rock Therapeutics include NIH RADx, National Institute on Alcohol Abuse and Alcoholism.
Will Seal Rock Therapeutics IPO soon?
No public IPO plans have been announced for Seal Rock Therapeutics.
How can I track Seal Rock Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Seal Rock Therapeutics's shares on secondary markets.